Cognitive Behavioral Therapy for Alcoholism and Cannabis Abuse
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you must be able to safely abstain from alcohol and cannabis for 12 hours before assessments.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy (CBT) for alcoholism and cannabis abuse?
Research shows that Cognitive Behavioral Therapy (CBT) is effective for treating both alcohol and cannabis use disorders. Studies have found that people who received CBT reported better outcomes, such as increased abstinence and fewer substance-related problems, compared to those who did not receive the treatment.12345
Is Cognitive Behavioral Therapy (CBT) safe for treating alcohol and cannabis use disorders?
How is Cognitive Behavioral Therapy (CBT) different from other treatments for alcoholism and cannabis abuse?
Cognitive Behavioral Therapy (CBT) is unique because it focuses on changing thought patterns and behaviors related to substance use, and it can be delivered in various formats, including computer-based programs, which makes it more accessible and flexible compared to traditional in-person therapy sessions.23569
What is the purpose of this trial?
This 2-arm study will recruit participants with 1) alcohol use disorder and 2) cannabis use disorder for a 12-week cognitive behavioral therapy, following a thorough baseline assessments on executive function, incentive salience, and negative emotionality.
Research Team
Matthew Sloan, MD
Principal Investigator
Centre for Addiction and Mental Health
Eligibility Criteria
This trial is for adults over 18 who have been diagnosed with alcohol use disorder (AUD) or cannabis use disorder (CUD), are willing to participate in group therapy, and can abstain from substances before assessments. They must meet specific criteria for risky drinking or frequent cannabis use. Those unable to communicate in English or unwilling to follow the study's abstinence requirements cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo thorough baseline assessments of executive function, incentive salience, and negative emotionality
Treatment
Participants receive 12 weeks of cognitive behavioral therapy (CBT) for their respective disorders, with optional pharmacotherapy for AUD and motivational enhancement therapy for CUD
Follow-up
Participants are monitored for changes in drug consumption, craving, and other psychological measures
Treatment Details
Interventions
- CBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
AFP Innovation Fund
Collaborator